The latest lymphoma news
A potent weapon against lymphomas
Researchers from the The Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association…
Browsing: Lymphoma
HIV positive and negative patients with lymphoma as a predictor of outcome and tumour proliferation
This authors of a new paper published in Oncotarget reported that the aim of this study is…
Moffitt researchers discover potential new drug target to treat cutaneous T cell lymphoma
Cutaneous T cell lymphomas (CTCLs) are a group of non-Hodgkin lymphomas that develop from T…
Researchers discover potential new drug target to treat cutaneous T cell lymphoma
Cutaneous T cell lymphomas (CTCLs) are a group of non-Hodgkin lymphomas that develop from T…
ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels…
Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma
The histone deacetylase (HDAC) inhibitor vorinostat (Zolinza) in combination with the mTOR inhibitor sirolimus (Rapamune)…
Many Non-Hodgkin’s Lymphoma patients can skip radiation, collaborative study finds
Skipping radiation and receiving less chemotherapy may become the new standard of care for some…
New therapeutic target identified for rare virus-associated lymphomas
Targeting a “cell survival” protein could be a valuable new approach to treating certain blood…
Study identifies characteristics of infused CAR-T cells associated with efficacy and toxicity in patients with large B-cell lymphoma
Researchers at The University of Texas MD Anderson Cancer Center, USA, have identified molecular and…